Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2011-04-26
2011-04-26
Badio, Barbara P (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C552S553000
Reexamination Certificate
active
07932244
ABSTRACT:
The present invention relates to compounds of formula (I):wherein R is hydrogen or alpha-hydroxy,the hydroxyl group in position 7 is in the alpha or beta position;and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof.
REFERENCES:
patent: 5014206 (1991-05-01), Scribner et al.
patent: 5121853 (1992-06-01), Edelhoff et al.
patent: 5326939 (1994-07-01), Schafer et al.
patent: 5392926 (1995-02-01), Schafer et al.
patent: 5565846 (1996-10-01), Geiszler et al.
patent: 6191691 (2001-02-01), Serrault et al.
patent: 6448898 (2002-09-01), Kasik
patent: 7078396 (2006-07-01), Song et al.
patent: 7138390 (2006-11-01), Pellicciari et al.
patent: 2003/0112155 (2003-06-01), Landre et al.
patent: 2004/0027243 (2004-12-01), Carrender
patent: 1392714 (2004-03-01), None
patent: 1568706 (2005-08-01), None
patent: WO-00/37077 (2000-06-01), None
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, pp. 217-218 (in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227).
Vippagunta et al. (Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26).
International Search Report for Application No. PCT/US07/14829 dated Dec. 12, 2007.
Fiorucci, S., et al., Gastroenterology (2004).
Forman, BM. et al., Cell 81:687-693 (1995).
Mangelsdorf, DJ., et al., Cell 83:841-850 (1995).
Pellicciari, R., et al., J. Med Chem. 15;45:3569-72 (2002).
Seol, W., et al., Mol. Endocrinnol. 9:72-85 (1995).
Russell, DW, Cell 97:539-542 (1999).
Fiorucci Stefano
Pellicciari Roberto
Pruzanski Mark
Badio Barbara P
Elrifi, Esq. Ivor R.
Intercept Pharmaceuticals, Inc.
Loebach, Esq. Jennifer L.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Bile acid derivatives as FXR ligands for the prevention or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bile acid derivatives as FXR ligands for the prevention or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bile acid derivatives as FXR ligands for the prevention or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2623408